Il tuo browser è obsoleto

Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore.

×

Skip to main content

LEFT MAIN STENTING Resolute Onyx DES

LEFT MAIN APPROACHES

This video was produced through a grant provided to euroPCR by Medtronic. The content of the video is not endorsed by Medtronic. Dr. Latib, Dr. Mendiz and Dr. Ghazzal are paid consultants of Medtronic.

 

This case is genuine, typical, and documented. Individual results may vary.

 

PREDICTABLE PERFORMANCE FOR ACCURATE STENT PLACEMENT1

Minimal foreshortening while maintaining coating integrity1

Resolute Onyx™ DES

5.0 mm x 18 mm
Deployed to 5.75 per IFU maximum overexpansion

Image of Resolute Onyx DES

Resolute Onyx DES Stent Foreshortening

Resolute Onyx DES stent 0.8 percent foreshortening for left main vessel placement.

Synergy™* DES

4.0 mm x 20 mm
Deployed to 5.75 per IFU maximum overexpansion

Image of Resolute Onyx DES

Synergy DES Stent Foreshortening

1

Based on bench test data. May not be indicative of clinical performance.

HIGH RADIOPACITY FOR PRECISE DEPLOYMENT

Resolute Onyx DES incorporates a platinum-iridium core with 2.6x density of the cobalt alloy shell—for improved radiopacity

  1. Integrity™ BMS
  2. Resolute Onyx DES
High Radiopacity for Precise Deployment

SUSTAINED RADIAL STRENGTH IN LARGE VESSELS

Sustained Radial Strength in Large Vessels

ADAPTABLE IN BIFURCATIONS

Excellent Flexibility and Conformability, with Continuous Sinusoid Technology, contribute to superior strut apposition1,2 — stent geometry facilitates side branch access and vessel apposition1

stents resolute-onyx sidebranch cell size

Resolute Onyx DES Open Cell Expansion Diameter

The Resolute Onyx DES cell can be expanded for side branch access.

synergy des sidebranch cell size

Synergy DES

4.0 mm x 20 mm

DES 4.0 mm x 18 mm

Xience Xpedition DES Closed Cell Expansion Diameter

The Xience Expedition DES closed cell expands to a smaller diameter than Resolute Onyx DES.

1

Bench test data on file at Medtronic. These tests and models may not be indicative of clinical performance.

2

Mortier JACC Card Interv. 2014; 7(3): 325-33.

Ready to learn more?

pdf Resolute Onyx DES Left Main Brochure (.pdf) (opens new window)

Resolute Onyx Left Brochure (opens new window)

Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.